Skip to main content
Caplight Logo









Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

Private
TianjinHealthcare & Life Scienceshttps://tjsjkt.com/

Last Round

Series B

Sep 20, 2023

Total Funding Raised

$2.94M

Company Overview

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is a medical device company that specializes in the research, development, production, and sale of high-end ophthalmic products, including intraocular lenses, optometry equipment, and biomaterial collagen.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

intraocular lensesIOLophthalmic medical devicesbiomaterial productsmyopia controlcataract surgeryorthokeratologyortho-kcollagen dressingsmedical aestheticssurgical consumablesrigid contact lensesophthalmologyClass III medical deviceswound care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Comparables

Compare Tianjin Century Healthcare Biomedical Engineering Co., Ltd. with similar companies based on industry and business-model similarity.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuxi Vision Pro
89%
Eyebright Medical Technology (Beijing) Co., Ltd.
83%
Shanghai Haohai Biological Technology Co. Ltd
81%

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 20, 2023
Series A ExtensionApr 1, 2023
Series AMay 26, 2022
AngelDec 1, 2021

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Investors

Notable investors and investment history

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. investors
InvestorRounds
SDIC Unity CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2024

    Monthly visitors grew 129% MoM, reaching 384.

  • Sep 20, 2023

    SDIC Unity Capital led the Series B round.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTianjin
Employee Range5
Year Founded2008
Last FundingSep 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?